51. Evaluation of ChatGPT Responses to Common Puberty Questions by Winograd, Deborah, Alterman, Carly, Appelbaum, Heather, Baum, Jonathan

Get full text

First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial by Janjigian, Yelena Y, MD, Maron, Steven B, MD, Chatila, Walid K, MS, Millang, Brittanie, MPH, Chavan, Shweta S, PhD, Alterman, Carly, BA, Chou, Joanne F, MPH, Segal, Michal F, RN, Simmons, Marc Z, MD, Momtaz, Parisa, MD, Shcherba, Marina, MD, Ku, Geoffrey Y, MD, Zervoudakis, Alice, MD, Won, Elizabeth S, MD, Kelsen, David P, Prof, Ilson, David H, Prof, Nagy, Rebecca J, MS, Lanman, Richard B, MD, Ptashkin, Ryan N, MS, Donoghue, Mark T A, PhD, Capanu, Marinela, PhD, Taylor, Barry S, PhD, Solit, David B, Prof, Schultz, Nikolaus, PhD, Hechtman, Jaclyn F, MD

Get full text

First-line pembrolizumab and trastuzumab in HER2-positive esophagogastric cancer by Janjigian, Yelena Y., Maron, Steven B., Chatila, Walid K., Millang, Brittanie, Chavan, Shweta S., Alterman, Carly, Chou, Joanne F., Simmons, Marc, Momtaz, Parisa, Shcherba, Marina, Ku, Geoffrey Y., Zervoudakis, Alice, Won, Elizabeth S., Kelsen, David P., Ilson, David H., Nagy, Rebecca J., Lanman, Richard B., Ptashkin, Ryan N., Donoghue, Mark T.A., Capanu, Marinela, Taylor, Barry S., Solit, David B., Schultz, Nikolaus, Hechtman, Jaclyn F.

Get full text